相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。RAS/MAPK Activation Is Associated with Reduced Tumor-Infiltrating Lymphocytes in Triple-Negative Breast Cancer: Therapeutic Cooperation Between MEK and PD-1/PD-L1 Immune Checkpoint Inhibitors
Sherene Loi et al.
CLINICAL CANCER RESEARCH (2016)
Tumor-infiltrating lymphocytes (TILs) are a powerful prognostic marker in patients with triple-negative breast cancer enrolled in the IBCSG phase III randomized clinical trial 22-00
Giancarlo Pruneri et al.
BREAST CANCER RESEARCH AND TREATMENT (2016)
Clinical implications of basic research in hepatocellular carcinoma
Renumathy Dhanasekaran et al.
JOURNAL OF HEPATOLOGY (2016)
Adaptive Randomization of Neratinib in Early Breast Cancer
J. W. Park et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Cancer immunotherapy targeting neoantigens
Yong-Chen Lu et al.
SEMINARS IN IMMUNOLOGY (2016)
Predictors of Chemosensitivity in Triple Negative Breast Cancer: An Integrated Genomic Analysis
Tingting Jiang et al.
PLOS MEDICINE (2016)
Immunogenic Subtypes of Breast Cancer Delineated by Gene Classifiers of Immune Responsiveness
Lance D. Miller et al.
CANCER IMMUNOLOGY RESEARCH (2016)
Immune Checkpoint Blockade to Improve Tumor Infiltrating Lymphocytes for Adoptive Cell Therapy
Krithika N. Kodumudi et al.
PLOS ONE (2016)
Androgen receptor expression as a prognostic and predictive marker in triple-negative breast cancer patients
Fatma Zakaria et al.
ALEXANDRIA JOURNAL OF MEDICINE (2016)
Prognostic Significance of Tumor-Infiltrating Lymphocytes and the Tertiary Lymphoid Structures in HER2-Positive Breast Cancer Treated With Adjuvant Trastuzumab
Hee Jin Lee et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2015)
PARP inhibitors in the management of breast cancer: current data and future prospects
Luca Livraghi et al.
BMC MEDICINE (2015)
Long-term outcome of HER2 positive metastatic breast cancer patients treated with first-line trastuzumab
B. Yeo et al.
BREAST (2015)
Cytotoxic T lymphocyte antigen 4 expression in human breast cancer: implications for prognosis
Haiming Yu et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2015)
Abscopal Responses in Metastatic Non-Small Cell Lung Cancer (NSCLC) Patients Treated on a Phase 2 Study of Combined Radiation Therapy and Ipilimumab: Evidence for the In Situ Vaccination Hypothesis of Radiation
E. B. Golden et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2015)
Tumor-Infiltrating Lymphocytes and Response to Neoadjuvant Chemotherapy With or Without Carboplatin in Human Epidermal Growth Factor Receptor 2-Positive and Triple-Negative Primary Breast Cancers
Carsten Denkert et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Immune Checkpoint Blockade in Cancer Therapy
Michael A. Postow et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Natural and therapy-induced immunosurveillance in breast cancer
Guido Kroemer et al.
NATURE MEDICINE (2015)
Immune evasion in cancer: Mechanistic basis and therapeutic strategies
Dass S. Vinay et al.
SEMINARS IN CANCER BIOLOGY (2015)
Concepts and mechanisms underlying chemotherapy induced immunogenic cell death: Impact on clinical studies and considerations for combined therapies
Simon Gebremeskel et al.
ONCOTARGET (2015)
Androgen Receptor Expression Predicts Decreased Survival in Early Stage Triple-Negative Breast Cancer
Jung Eun Choi et al.
ANNALS OF SURGICAL ONCOLOGY (2015)
Prognostic significance of tumor-infiltrating CD8+ and FOXP3+ lymphocytes in residual tumors and alterations in these parameters after neoadjuvant chemotherapy in triple-negative breast cancer: a retrospective multicenter study
Minoru Miyashita et al.
BREAST CANCER RESEARCH (2015)
Tumor infiltrating lymphocytes are prognostic in triple negative breast cancer and predictive for trastuzumab benefit in early breast cancer: results from the FinHER trial
S. Loi et al.
ANNALS OF ONCOLOGY (2014)
The immunogenicity of breast cancer-molecular subtypes matter
C. Denkert
ANNALS OF ONCOLOGY (2014)
Accumulation of Memory Precursor CD8 T Cells in Regressing Tumors following Combination Therapy with Vaccine and Anti-PD-1 Antibody
Lavakumar Karyampudi et al.
CANCER RESEARCH (2014)
Multiplexed Quantitative Analysis of CD3, CD8, and CD20 Predicts Response to Neoadjuvant Chemotherapy in Breast Cancer
Jason R. Brown et al.
CLINICAL CANCER RESEARCH (2014)
Adoptive cellular immunotherapy for the treatment of patients with breast cancer: A meta-analysis
Zheng-Xu Wang et al.
CYTOTHERAPY (2014)
Neo-antigens predicted by tumor genome meta-analysis correlate with increased patient survival
Scott D. Brown et al.
GENOME RESEARCH (2014)
Combination of sunitinib with anti-tumor vaccination inhibits T cell priming and requires careful scheduling to achieve productive immunotherapy
Ritika Jaini et al.
INTERNATIONAL JOURNAL OF CANCER (2014)
Prognostic Value of Tumor-Infiltrating Lymphocytes in Triple-Negative Breast Cancers From Two Phase III Randomized Adjuvant Breast Cancer Trials: ECOG 2197 and ECOG 1199
Sylvia Adams et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
Immunotherapy Converts Nonimmunogenic Pancreatic Tumors into Immunogenic Foci of Immune Regulation
Eric R. Lutz et al.
CANCER IMMUNOLOGY RESEARCH (2014)
PD-L1 Expression in Triple-Negative Breast Cancer
Elizabeth A. Mittendorf et al.
CANCER IMMUNOLOGY RESEARCH (2014)
Androgen Receptor Expression in Early Triple-Negative Breast Cancer: Clinical Significance and Prognostic Associations
Mirco Pistelli et al.
CANCERS (2014)
Active immunotherapy in HER2 overexpressing breast cancer: current status and future perspectives
A. Milani et al.
ANNALS OF ONCOLOGY (2013)
Pertuzumab plus trastuzumab in combination with standard neoadjuvant anthracycline-containing and anthracycline-free chemotherapy regimens in patients with HER2-positive early breast cancer: a randomized phase II cardiac safety study (TRYPHAENA)
A. Schneeweiss et al.
ANNALS OF ONCOLOGY (2013)
Prevalence of BRCA Mutations Among Women with Triple-Negative Breast Cancer (TNBC) in a Genetic Counseling Cohort
Rachel Greenup et al.
ANNALS OF SURGICAL ONCOLOGY (2013)
Immunogenic Cell Death in Cancer Therapy
Guido Kroemer et al.
ANNUAL REVIEW OF IMMUNOLOGY, VOL 31 (2013)
HER2 Dimerization Inhibitor Pertuzumab - Mode of Action and Clinical Data in Breast Cancer
Nadia Harbeck et al.
BREAST CARE (2013)
Differential Response to Neoadjuvant Chemotherapy Among 7 Triple-Negative Breast Cancer Molecular Subtypes
Hiroko Masuda et al.
CLINICAL CANCER RESEARCH (2013)
被撤回的出版物: FoxP3 Acts as a Cotranscription Factor with STAT3 in Tumor-Induced Regulatory T Cells (Retracted article. See vol. 54, pg. 2167, 2021)
Dewan Md Sakib Hossain et al.
IMMUNITY (2013)
CD4+ follicular helper T cell infiltration predicts breast cancer survival
Chunyan Gu-Trantien et al.
JOURNAL OF CLINICAL INVESTIGATION (2013)
Microenvironmental regulation of tumor progression and metastasis
Daniela F. Quail et al.
NATURE MEDICINE (2013)
An Abscopal Response to Radiation and Ipilimumab in a Patient with Metastatic Non-Small Cell Lung Cancer
Encouse B. Golden et al.
CANCER IMMUNOLOGY RESEARCH (2013)
Decreased Androgen Receptor Expression Is Associated With Distant Metastases in Patients With Androgen Receptor Expressing Triple-Negative Breast Carcinoma
Lisa M. Sutton et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2012)
Efficacy and safety of neoadjuvant pertuzumab and trastuzumab in women with locally advanced, inflammatory, or early HER2-positive breast cancer (NeoSphere): a randomised multicentre, open-label, phase 2 trial
Luca Gianni et al.
LANCET ONCOLOGY (2012)
Trastuzumab Emtansine for HER2-Positive Advanced Breast Cancer
Sunil Verma et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Olaparib Maintenance Therapy in Platinum-Sensitive Relapsed Ovarian Cancer
Jonathan Ledermann et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Pertuzumab plus Trastuzumab plus Docetaxel for Metastatic Breast Cancer
Jose Baselga et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Targeting PD-1/PD-L1 interactions for cancer immunotherapy
Laurence Zitvogel et al.
ONCOIMMUNOLOGY (2012)
Natural Innate and Adaptive Immunity to Cancer
Matthew D. Vesely et al.
ANNUAL REVIEW OF IMMUNOLOGY, VOL 29 (2011)
Roles of the immune system in skin cancer
S. Rangwala et al.
BRITISH JOURNAL OF DERMATOLOGY (2011)
Human Tumor Cells Killed by Anthracyclines Induce a Tumor-Specific Immune Response
Jitka Fucikova et al.
CANCER RESEARCH (2011)
Hallmarks of Cancer: The Next Generation
Douglas Hanahan et al.
CELL (2011)
Human breast cancer cells enhance self tolerance by promoting evasion from NK cell antitumor immunity
Emilie Mamessier et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies
Brian D. Lehmann et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
Tumor-Infiltrating CD8+ Lymphocytes Predict Clinical Outcome in Breast Cancer
Sahar M. A. Mahmoud et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
In situ immune response after neoadjuvant chemotherapy for breast cancer predicts survival
Sylvain Ladoire et al.
JOURNAL OF PATHOLOGY (2011)
Leukocyte Complexity Predicts Breast Cancer Survival and Functionally Regulates Response to Chemotherapy
David G. DeNardo et al.
CANCER DISCOVERY (2011)
Tumor-associated Macrophages (TAM) and Inflammation in Colorectal Cancer
Marco Erreni et al.
CANCER MICROENVIRONMENT (2011)
The Canonical NF-κB Pathway Governs Mammary Tumorigenesis in Transgenic Mice and Tumor Stem Cell Expansion
Manran Liu et al.
CANCER RESEARCH (2010)
Immunity, Inflammation, and Cancer
Sergei I. Grivennikov et al.
CELL (2010)
Tremelimumab in Combination with Exemestane in Patients with Advanced Breast Cancer and Treatment-Associated Modulation of Inducible Costimulator Expression on Patient T Cells
Robert H. Vonderheide et al.
CLINICAL CANCER RESEARCH (2010)
Identification of Subtypes in Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer Reveals a Gene Signature Prognostic of Outcome
Johan Staaf et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Tumor-Associated Lymphocytes As an Independent Predictor of Response to Neoadjuvant Chemotherapy in Breast Cancer
Carsten Denkert et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
B-cell-derived lymphotoxin promotes castration-resistant prostate cancer
Massimo Ammirante et al.
NATURE (2010)
Elevated Biomarkers of Inflammation Are Associated With Reduced Survival Among Breast Cancer Patients
Brandon L. Pierce et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Activation of the NLRP3 inflammasome in dendritic cells induces IL-1β-dependent adaptive immunity against tumors
Francois Ghiringhelli et al.
NATURE MEDICINE (2009)
Pathologic complete response to neoadjuvant chemotherapy of breast carcinoma is associated with the disappearance of tumor-infiltrating Foxp3+ regulatory T cells
Sylvain Ladoire et al.
CLINICAL CANCER RESEARCH (2008)
Immunoglobulin G fragment C receptor polymorphisms and clinical efficacy of trastuzumab-based therapy in patients with HER-2/neu-positive metastatic breast cancer
Antonino Musolino et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Immune-mediated dormancy: an equilibrium with cancer
Michele W. L. Teng et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2008)
Molecular origins of cancer - Cancer immunology
Olivera J. Finn
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Immunological aspects of cancer chemotherapy
Laurence Zitvogel et al.
NATURE REVIEWS IMMUNOLOGY (2008)
Mast cells are required for angiogenesis and macroscopic expansion of Myc-induced pancreatic islet tumors
Laura Soucek et al.
NATURE MEDICINE (2007)
Toll-like receptor 4-dependent contribution of the immune system to anticancer chemotherapy and radiotherapy
Lionel Apetoh et al.
NATURE MEDICINE (2007)
Immune surveillance of tumors
Jeremy B. Swann et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
Cancer immunoediting from immune surveillance to immune escape
Ryungsa Kim et al.
IMMUNOLOGY (2007)
Induced sensitization of tumor stroma leads to eradication of established cancer by T cells
Bin Zhang et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2007)
An immune response gene expression module identifies a good prognosis subtype in estrogen receptor negative breast cancer
Andrew E. Teschendorff et al.
GENOME BIOLOGY (2007)
Calreticulin exposure dictates the immunogenicity of cancer cell death
Michel Obeid et al.
NATURE MEDICINE (2007)
Prognostic markers in triple-negative breast cancer
Emad A. Rakha et al.
CANCER (2007)
Lapatinib plus capecitabine for HER2-positive advanced breast cancer
Charles E. Geyer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Adoptive immunotherapy of breast cancer with lymph node cells primed by cryoablation of the primary tumor
Michael S. Sabel et al.
CRYOBIOLOGY (2006)
Radiation modulates the peptide repertoire, enhances MHC class I expression, and induces successful antitumor immunotherapy
Eric A. Reits et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2006)
Mechanisms of disease: understanding resistance to HER2-targeted therapy in human breast cancer
Rita Nahta et al.
NATURE CLINICAL PRACTICE ONCOLOGY (2006)
Paradoxical roles of the immune system during cancer development
KE de Visser et al.
NATURE REVIEWS CANCER (2006)
Caspase-dependent immunogenicity of doxorubicin-induced tumor cell death
N Casares et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2005)
Poly(ADP-ribose) polymerase (PARP-1) in homologous recombination and as a target for cancer therapy
T Helleday et al.
CELL CYCLE (2005)
Opinion - Immunotherapy and chemotherapy - a practical partnership
RA Lake et al.
NATURE REVIEWS CANCER (2005)
Inhibition of CD4+25+ T regulatory cell function implicated in enhanced immune response by low-dose cyclophosphamide
MEC Lutsiak et al.
BLOOD (2005)
Breast cancer in women with HIV/AIDS: Report of five cases with a review of the literature
SF Oluwole et al.
JOURNAL OF SURGICAL ONCOLOGY (2005)
Prognostic value of tumor-infiltrating dendritic cells expressing CD83 in human breast carcinomas
M Iwamoto et al.
INTERNATIONAL JOURNAL OF CANCER (2003)
IFNγ and lymphocytes prevent primary tumour development and shape tumour immunogenicity
V Shankaran et al.
NATURE (2001)
Inflammation and cancer: back to Virchow?
F Balkwill et al.
LANCET (2001)
Inhibitory Fc receptors modulate in vivo cytoxicity against tumor targets
RA Clynes et al.
NATURE MEDICINE (2000)
分享论文
